AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00112073 · COMPLETED
Trial details
- NCT number
- NCT00112073
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2008-11-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.